marketcaparena
Search

    INO

    INOVIO PHARMACEUTICALS, INC.

    Company overview

    Market capitalization
    $120.98M
    Employees
    112
    Latest publication
    2026-09-29
    About INOVIO PHARMACEUTICALS, INC.

    Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade squamous intraepithelial lesions; INO-3112 for the treatment of HPV-related Oropharyngeal squamous cell carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 2/3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. The company's partners and collaborators ApolloBio Corporation, AstraZeneca, Coherus Biosciences, Defense Advanced Research Projects Agency, HIV Vaccines Trial Network, Kaneka Eurogentec, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the University of Pennsylvania, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue0USD0USD-65,343USD0USD0USD65,343USD116,994USD0USD
    Research Development10,826,549USD13,753,263USD10,261,236USD13,333,329USD14,165,256USD16,090,902,000USD12,885,449USD18,733,584USD
    Selling General Administrative7,797,973USD7,879,886,000USD7,215,365USD7,877,126USD8,563,112,000USD9,024,970,000USD7,601,106USD8,613,895,000USD
    General And Administrative Expenses7,797,973USD———————
    Total Operating Expenses18,624,522USD21,204,529USD16,722,546USD21,210,455USD22,342,849USD25,115,872,000USD19,710,726USD27,347,479USD
    Operating Income-18,624,522USD-21,949,993USD-17,476,601USD-21,210,455USD-23,084,519USD-25,050,529USD-20,369,561USD-27,347,479USD
    Total Other Income Expense Net-1,714,620USD2,267,195USD21,241,481USD-24,286,217USD-434,893USD5,355,832,000USD987,882USD-25,138,130,521USD
    Interest Income363,847USD439,593USD449,337USD552,108USD610,638USD808,077USD852,587USD1,106,758USD
    Net Income-6,012,458USD-19,682,798USD3,764,880USD-45,496,672USD-23,519,412USD-19,694,697USD-19,381,679USD-25,165,478USD
    Cost Of Revenue—745,464USD754,054USD749,656USD741,670USD—775,829USD765,858USD
    Gross Profit—-745,464USD-754,054USD-749,656USD-741,670USD65,343USD-658,835USD-765,858USD
    Unclassified Operating Expenses—-7,872,434,734USD——-8,554,934,407USD——-8,605,281,105USD
    Net Interest Income—439,593USD449,337USD552,108USD610,638USD808,077USD852,587USD1,106,758USD
    Income Before Tax—-19,682,798USD3,764,880USD-45,496,672USD-23,519,412USD-19,694,697USD-19,381,679USD-25,165,478USD
    Net Income From Continuing Ops—-19,682,798USD3,764,880USD-45,496,672USD-23,519,412USD-19,694,697USD-19,381,679USD-25,165,478USD
    Ebit—-21,949,993USD3,764,880USD-45,496,672USD-23,519,412USD-25,051,272,450USD-19,381,682USD-25,165,478USD
    Ebitda—-21,204,529USD4,518,934USD-44,747,016USD-22,777,742USD-25,050,529,000USD-18,605,853USD-24,399,620USD
    Depreciation And Amortization—745,464USD754,054USD749,656USD741,670USD743,450USD775,829USD765,858USD
    Reconciled Depreciation—745,464USD754,054USD749,656USD741,670USD743,450USD775,829USD765,858USD
    Interest Expense——0USD0USD0USD0USD0USD0USD
    Income Tax Expense——————-716,454USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue65,343USD217,756USD832,010USD10,262,268USD1,774,758USD7,411,220USD4,111,930USD30,481,897USD
    Cost Of Revenue2,988,830USD3,130,042USD3,503,538USD5,496,026USD4,730,781USD94,245,436USD88,017,319USD95,257,876USD
    Gross Profit65,343USD-2,912,286USD832,010USD10,262,268USD1,774,758USD7,411,220USD4,111,930USD30,481,897USD
    Research Development54,206,874USD75,620,340USD86,676,563USD187,650,503USD249,240,324USD94,245,436USD88,017,319USD95,257,876USD
    Selling General Administrative32,680,573USD36,996,338,000USD47,582,104USD90,185,285USD53,752,353USD37,247,828USD27,203,156USD29,315,159USD
    Total Operating Expenses86,887,447USD111,086,636USD144,772,038USD277,835,788USD302,992,677USD131,493,264USD115,220,475USD124,573,035USD
    Operating Income-86,822,104USD-112,398,922USD-143,940,028USD-267,573,520USD-301,217,919USD-124,082,044USD-111,108,545USD-94,091,138USD
    Interest Income2,420,160USD4,766,993USD8,202,939USD4,782,030USD3,363,080USD3,311,846USD2,605,981USD706,880USD
    Interest Expense0USD177,833USD1,222,789USD1,253,952USD1,936,447USD8,702,450USD7,948,539USD346,086USD
    Net Interest Income2,420,160USD4,589,160USD6,948,987USD3,528,078USD1,426,633USD-5,390,604USD-5,342,558USD920,891USD
    Income Before Tax-84,945,901USD-107,254,126USD-135,117,352USD-279,818,065USD-303,658,710USD-167,474,914USD-120,809,112USD-94,798,019USD
    Net Income-84,945,901USD-107,254,126USD-135,117,352USD-279,818,065USD-303,658,710USD-166,411,157USD-119,359,219USD-96,967,830USD
    Net Income From Continuing Ops-84,945,901USD-107,254,126USD-164,576,853USD-277,652,852USD-303,224,323USD-162,890,304USD-120,509,112USD-96,968,019USD
    Ebit-84,945,901USD-107,076,289USD-133,894,563USD-276,398,900USD-301,287,876USD-154,187,854USD-112,860,573USD-94,798,023USD
    Ebitda-81,957,071USD-103,946,247USD-130,391,025USD-270,902,874USD-296,557,095USD-149,560,064USD-107,344,131USD-89,801,256USD
    Depreciation And Amortization2,988,830USD3,130,042USD3,503,538USD5,496,026USD4,730,781USD4,627,790USD5,516,442USD4,996,767USD
    Reconciled Depreciation2,988,830USD3,130,042USD4,676,805USD5,496,026USD4,730,781USD4,627,790USD5,516,442USD4,996,767USD
    Total Other Income Expense Net1,876,203USD-107,141,727,078USD8,822,676USD-12,244,545USD-2,440,791USD-43,392,870USD-9,700,567USD-706,881USD
    Unclassified Operating Expenses—-36,960,871,704USD7,009,833USD—————
    Income Tax Expense—-107,146,871,874USD2USD2,165,213USD434,387USD52,196,140USD-257,335USD2,169,811USD
    Net Income Applicable To Common Shares—-107,254,126USD-135,117,352USD-279,818,065USD-303,658,710USD-166,411,157USD-119,359,219USD-96,968,019USD
    Selling And Marketing Expenses——3,503,538USD—————
    Non Operating Income Net Other———-1,244,767USD3,272,064USD-72,942,575USD1,338,529USD1,281,686USD
    Minority Interest———0USD0USD-1,063,757USD-1,192,558USD96,269USD
    Tax Provision————0USD-87,764USD-257,335USD2,169,811USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets49,389,494USD49,777,142USD74,310,035USD69,385,656USD68,240,504USD87,272,659USD113,197,206USD107,059,674USD
    Cash And Equivalents31,526,164USD———————
    Cash And Short Term Investments36,674,017USD37,681,257USD58,512,464USD50,803,190USD47,549,460USD68,362,544USD94,113,529USD84,804,768USD
    Short Term Investments5,147,853USD11,409,607USD14,239,145USD14,235,770USD23,198,083USD28,447,097USD28,300,232USD63,117,288USD
    Total Current Assets39,913,249USD39,439,605USD61,123,346USD55,180,314USD52,697,149USD71,894,449USD97,830,050USD91,284,623USD
    Other Current Assets3,239,232USD1,758,348USD2,610,432USD3,398,534USD4,307,377USD2,221,668USD2,517,465USD4,617,116USD
    Other Non Current Assets1,917,069USD———————
    Total Liabilities45,018,411USD———————
    Total Current Liabilities39,915,059USD37,923,025USD43,668,555USD69,823,896USD31,707,610USD27,326,880USD35,325,584USD23,499,137USD
    Total Stockholder Equity4,371,083USD6,067,882USD24,096,276USD-7,719,977USD28,530,905USD51,250,724USD68,503,795USD73,540,310USD
    Total Equity Including Noncontrolling Interest4,371,083USD———————
    Property Plant Equipment Net7,559,176USD8,325,062USD9,070,526USD9,697,136USD10,445,531USD11,089,581USD11,773,658USD12,564,410USD
    Short Term Debt2,898,637USD2,908,820USD2,822,622USD2,738,490USD2,656,239USD2,575,902USD2,497,360USD2,425,112USD
    Common Stock82,342USD69,773USD68,997USD53,572USD36,719USD36,674USD36,099USD26,051USD
    Retained Earnings-1,840,860,419USD-1,834,847,961USD-1,815,165,163USD-1,818,930,043USD-1,773,433,371USD-1,749,913,959USD-1,730,219,262USD-1,710,837,583USD
    Accumulated Other Comprehensive Income-279,976USD-636,093USD-637,963USD-647,356USD-661,742USD-661,320USD-675,667USD-623,461USD
    Total Liab—43,709,260USD50,213,759USD77,105,633USD39,709,599USD36,021,935USD44,693,411USD33,519,364USD
    Other Current Liab—33,026,004USD38,226,785USD61,182,050USD23,567,857USD19,226,759USD26,385,558USD15,688,525USD
    Capital Stock—69,773USD68,997USD53,572USD36,719USD36,674USD36,099USD26,051USD
    Other Assets—1USD—————-91,193,338,377USD
    Cash—26,271,650USD44,273,319USD36,567,420USD24,351,377USD39,915,447USD65,813,297USD21,687,480USD
    Net Debt—-17,576,595USD-34,905,493USD-26,547,193USD-13,693,149USD-28,644,490USD-53,948,110USD-9,242,141USD
    Short Long Term Debt Total—8,695,055USD9,367,826USD10,020,227USD10,658,228USD11,270,957USD11,865,187USD12,445,339USD
    Long Term Investments—0USD2,103,688USD2,495,730USD3,085,348USD2,308,975USD1,613,844USD2,644,226USD
    Accounts Payable—1,988,201USD2,619,148USD5,903,356USD5,483,514USD5,524,219USD6,442,666USD5,385,500USD
    Property Plant Equipment Gross—8,325,062USD26,492,498USD9,697,136USD10,445,531USD11,089,581USD28,236,105USD12,564,410USD
    Common Stock Shares Outstanding—691,019,000shares468,864,000shares52,169,000shares38,830,053shares27,160,863shares27,160,863shares28,140,497shares
    Non Current Assets Total—10,337,536USD13,186,689USD14,205,341USD15,543,355USD15,378,210USD15,367,156USD15,775,051USD
    Non Current Liabilities Total—5,786,234USD6,545,204USD7,281,736USD8,001,989USD8,695,055USD9,367,827USD10,020,227USD
    Non Currrent Assets Other—2,012,474USD2,012,475USD2,012,475USD2,012,476USD1,979,654USD1,979,654USD566,415USD
    Net Working Capital—1,516,580USD17,454,791USD-14,643,582USD20,989,539USD44,567,569USD62,504,466USD67,785,486USD
    Unclassified Non Current Liabilities—5,786,234USD6,545,204USD7,281,736USD8,001,989USD8,695,055USD9,367,827USD10,020,227USD
    Unclassified Equity—1,841,412,390USD1,839,761,408USD1,811,750,278USD1,802,552,580USD1,801,752,655USD1,799,326,526USD1,784,949,252USD
    Net Receivables——450USD978,590USD840,312USD1,310,237USD1,199,056USD1,862,739USD
    Inventory———————86,576,222,377USD
    Unclassified Current Assets———————-86,576,222,377USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets74,310,035USD113,197,206USD170,951,423USD348,533,302USD495,941,493USD539,772,472USD143,951,597USD131,113,265USD
    Other Current Assets2,610,432USD2,517,465USD5,414,097USD50,505,708USD39,098,183USD40,463,888USD2,634,738USD2,527,395USD
    Total Liab50,213,759USD44,693,411USD53,602,294USD126,170,546USD96,272,072USD78,631,714USD138,546,739USD44,080,858USD
    Total Stockholder Equity24,096,276USD68,503,795USD117,349,129USD222,362,756USD399,669,421USD461,140,758USD3,435,099USD86,936,138USD
    Other Current Liab38,226,785USD26,385,558USD18,744,707USD72,981,175USD35,143,274USD37,861,447USD22,141,541USD24,020,999USD
    Common Stock68,997USD36,099USD22,792USD21,090USD217,382USD186,851USD101,361USD97,226USD
    Capital Stock68,997USD36,099USD22,792USD253,090USD217,382USD186,851USD101,361USD97,226USD
    Retained Earnings-1,815,165,163USD-1,730,219,262USD-1,622,965,136USD-1,487,847,784USD-1,209,855,522USD-906,196,812USD-739,785,655USD-620,426,436USD
    Cash44,273,319USD65,813,297USD14,310,862USD46,329,359USD71,143,778USD250,728,118USD22,196,097USD23,693,633USD
    Cash And Short Term Investments58,512,464USD94,113,529USD145,293,775USD252,998,756USD401,314,718USD411,643,053USD89,534,114USD81,232,485USD
    Total Current Assets61,123,346USD97,830,050USD153,113,100USD315,242,680USD448,444,945USD471,170,690USD94,200,969USD87,814,824USD
    Total Current Liabilities43,668,555USD35,325,584USD42,570,228USD96,868,074USD65,741,633USD41,705,954USD31,989,321USD35,299,759USD
    Net Debt-34,905,493USD-53,948,110USD15,898,380USD-14,254,960USD-38,120,616USD-211,679,387USD77,311,584USD-23,693,633USD
    Short Term Debt2,822,622USD2,497,360USD19,177,176USD2,803,973USD2,603,956USD2,329,394USD2,074,842USD—
    Short Long Term Debt Total9,367,826USD11,865,187USD30,209,242USD32,074,399USD33,023,162USD39,048,731USD99,507,681USD—
    Long Term Investments2,103,688USD1,613,844USD2,780,287USD2,007,142USD3,906,796USD434,387USD6,315,356USD6,381,926USD
    Short Term Investments14,239,145USD28,300,232USD130,982,913USD206,669,397USD330,170,940USD160,914,935USD67,338,017USD57,538,852USD
    Net Receivables450USD1,199,056USD2,405,228USD11,738,216USD8,032,044USD19,063,749USD2,032,117USD4,054,944USD
    Accounts Payable2,619,148USD6,442,666USD4,648,345USD21,082,926USD27,972,775USD1,468,485USD7,648,810USD11,021,608USD
    Property Plant Equipment Net9,070,526USD11,773,658USD14,452,721USD17,956,204USD29,024,232USD24,089,440USD26,556,026USD15,949,014USD
    Property Plant Equipment Gross26,492,498USD28,236,105USD35,304,634USD17,956,204USD47,968,610USD24,089,440USD26,556,026USD15,949,014USD
    Accumulated Other Comprehensive Income-637,963USD-675,667USD-662,601USD-698,741USD-282,236USD-256,150USD472,608USD-528,867USD
    Common Stock Shares Outstanding468,864,000shares27,160,863shares22,173,750shares19,885,182shares214,622,765shares169,865,971shares124,623,263shares92,539,997shares
    Non Current Assets Total13,186,689USD15,367,156USD17,838,323USD33,290,622USD47,496,548USD68,601,782USD49,750,628USD43,298,441USD
    Non Current Liabilities Total6,545,204USD9,367,827USD11,032,066USD29,302,472USD30,530,439USD36,925,760USD106,557,418USD8,781,099USD
    Non Currrent Assets Other2,012,475USD1,979,654USD605,315USD684,044USD1,425,794USD25,957,448USD2,672,024USD2,669,998USD
    Net Working Capital17,454,791USD62,504,466USD110,542,872USD218,374,606USD382,703,312USD429,464,736USD62,211,648USD52,515,065USD
    Unclassified Non Current Liabilities6,545,204USD9,367,827USD11,032,066USD—15,444,733USD18,005,852USD20,372,979USD—
    Unclassified Equity1,839,761,408USD1,799,326,526USD1,740,931,282USD1,710,635,101USD1,609,372,415USD1,367,220,018USD742,545,424USD707,696,989USD
    Other Assets—-1,704,000USD1USD684,044USD1,425,794USD43,593,497USD2,672,024USD2,669,998USD
    Good Will——0USD10,513,371USD10,513,371USD10,513,371USD10,513,371USD10,513,371USD
    Current Deferred Revenue——1,038,908USD—21,628USD46,628USD124,128USD257,152USD
    Short Long Term Debt——16,770,654USD—————
    Unclassified Current Liabilities——-17,809,562USD—————
    Intangible Assets———2,129,861USD2,626,355USD3,146,770USD3,693,851USD4,760,145USD
    Deferred Long Term Liab———32,046USD————
    Other Liab———32,046USD111,233USD206,423USD9,124,579USD8,781,099USD
    Long Term Debt———16,614,840USD14,959,647USD18,655,822USD77,022,917USD—
    Non Current Liabilities Other———12,655,586USD14,826USD57,663USD36,943USD87,333USD
    Net Tangible Assets———209,719,524USD386,529,695USD447,480,617USD-10,772,123USD71,662,622USD
    Unclassified Non Current Assets————-1,425,794USD-39,133,131USD-2,672,024USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-19,682,798USD3,764,880USD-45,496,672USD-23,519,412USD-19,694,697USD-19,381,679USD-87,809,740USD-32,237,098USD
    Depreciation745,464USD754,054USD749,656USD741,670USD743,450USD775,829USD765,858USD828,625USD
    Stock Based Compensation698,744,000USD764,561USD757,086USD834,792USD1,399,349USD1,315,764USD5,275,304USD1,514,053USD
    Other Non Cash Items-1,139,720USD-20,845,294USD23,146,863USD1,037,233USD-4,548,141USD-1,642,777USD-1,819,145USD-91,738USD
    Change In Working Capital-1,514,262USD-3,808,750USD-730,428USD94,358USD-4,773,988USD-731,046USD-2,859,462USD1,776,808USD
    Total Cash From Operating Activities-21,591,316USD-19,370,549USD-21,573,495USD-20,811,359USD-26,874,027USD-19,663,909USD-84,355,674USD-28,209,350USD
    Capital Expenditures-4USD-127,444USD-67,951USD-30,930USD-59,373USD0USD-487,832USD-452,254USD
    Free Cash Flow-21,591,320USD-19,497,993USD-21,641,446USD-20,842,289USD-26,933,400USD-19,663,909USD-84,355,186USD-28,661,604USD
    Investments2,635,857USD69,255USD8,867,233USD5,282,066USD-51,753USD34,644,324USD14,077,766USD9,966,314USD
    Total Cashflows From Investing Activities2,635,857USD-58,189USD8,867,233USD5,282,066USD-51,753USD34,644,324USD69,371,366,051USD9,966,314USD
    Total Cash From Financing Activities953,790USD27,134,637USD24,922,305USD-34,777USD1,027,930USD29,145,402USD660,648USD33,033,611USD
    Issuance Of Capital Stock1,084,027USD26,621,316USD7,185,128USD0USD1,102,149USD13,081,606USD667,066USD17,059,668USD
    Change In Cash-18,001,669USD7,705,899USD12,216,043USD-15,564,070USD-25,897,850USD44,125,817USD-12,704,924USD14,790,575USD
    Begin Period Cash Flow44,273,319USD36,567,420USD24,351,377USD39,915,447USD65,813,297USD21,687,480USD34,392,404USD19,601,829USD
    End Period Cash Flow26,271,650USD44,273,319USD36,567,420USD24,351,377USD39,915,447USD65,813,297USD21,687,480USD34,392,404USD
    Other Cashflows From Investing Activities-284,690,000USD-69,281,816USD-250,914,373USD-738,401,070USD-59,795,627USD59,319USD-1,766,791,000USD—
    Other Cashflows From Financing Activities-130,237USD26,107,734,930USD-1,787USD-34,777USD-74,219USD16,063,796USD-6,418USD15,973,943USD
    Unclassified Operating Cash Flow-698,744,000USD—————2,091,511USD—
    Unclassified Investing Cash Flow284,690,004USD69,281,816USD250,982,324USD738,432,000USD59,855,000USD—71,124,567,117USD—
    Change To Account Receivables—-109,396,181USD-138,278USD469,925USD-111,181USD663,683USD541,857USD777,417USD
    Net Borrowings—0USD0USD0USD0USD0USD0USD—
    Unclassified Financing Cash Flow—-26,107,221,609USD17,738,964USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-84,945,901USD-107,254,126USD-135,117,352USD-279,818,065USD-303,658,710USD-167,474,914USD-120,551,777USD-96,967,830USD
    Depreciation2,988,830USD3,130,042USD3,503,538USD5,496,026USD4,730,781USD4,627,790USD5,516,442USD4,996,767USD
    Stock Based Compensation3,755,788USD6,595,108USD11,072,486USD22,555,419USD26,336,764USD15,647,523USD10,901,320USD10,654,622USD
    Other Non Cash Items-1,209,339USD-3,882,625USD6,467,515USD11,687,085USD6,531,195USD2,363,916USD10,087,818USD-360,795USD
    Change In Working Capital-9,218,808USD-2,664,952USD-10,259,692USD19,834,153USD50,351,445USD-71,071,816USD-3,543,121USD4,709,418USD
    Total Cash From Operating Activities-88,629,430USD-104,076,553USD-124,365,551USD-216,215,421USD-215,708,525USD-177,979,046USD-97,850,136USD-73,550,156USD
    Capital Expenditures-285,698USD-487,832USD-320,898USD-969,153USD-1,231,006USD-1,520,665USD-987,926USD-2,085,022USD
    Free Cash Flow-88,915,128USD-104,564,385USD-124,686,449USD-217,184,574USD-216,939,531USD-179,499,711USD-98,838,062USD-75,635,178USD
    Investments14,325,055USD104,071,039USD121,413,404USD112,555,007USD-174,113,478USD-93,225,654USD-8,057,069USD44,504,930USD
    Total Cashflows From Investing Activities14,039,357USD104,071,039USD87,355,875USD109,585,856USD-175,344,484USD-58,795,751USD-9,044,995USD42,419,908USD
    Net Borrowings0USD-16,415,000USD0USD0USD0USD171,620USD94,128,860USD97,443,617USD
    Total Cash From Financing Activities53,050,095USD51,475,546USD4,995,099USD81,840,702USD211,498,803USD465,279,613USD105,397,595USD31,037,302USD
    Issuance Of Capital Stock34,908,593USD36,033,473USD10,291,459USD82,955,311USD209,441,410USD454,486,400USD9,089,010USD29,227,776USD
    Change In Cash-21,539,978USD51,502,435USD-32,018,497USD-24,814,419USD-179,584,340USD228,532,021USD-1,497,536USD-92,946USD
    Begin Period Cash Flow65,813,297USD14,310,862USD46,329,359USD71,143,778USD250,728,118USD22,196,097USD23,693,633USD23,786,579USD
    End Period Cash Flow44,273,319USD65,813,297USD14,310,862USD46,329,359USD71,143,778USD250,728,118USD22,196,097USD23,693,633USD
    Other Cashflows From Investing Activities-1,176,328,302USD59,319USD6,219,263USD110,555,009USD-1,435,821,000,000USD-2,774,851USD-987,926,000,000USD-2,779,494,000,000USD
    Other Cashflows From Financing Activities-110,783USD-420,795USD-466,646USD-1,114,609USD2,057,393USD10,621,593USD-1,135,032USD1,809,526USD
    Unclassified Investing Cash Flow1,176,328,302USD—-39,955,894USD-112,555,007USD1,435,821,000,000USD38,725,419USD987,926,000,000USD2,779,494,000,000USD
    Unclassified Financing Cash Flow18,252,285USD32,277,868USD-4,829,714USD84,352,942USD214,052,758USD462,371,134USD106,532,667USD-67,604,231USD
    Change To Account Receivables—1,206,172USD9,332,988USD-3,706,172USD11,031,705USD-17,015,471USD2,022,827USD2,434,880USD
    Change To Liabilities———32,591,755USD26,098,133USD3,272,198USD-4,634,399USD-2,251,539USD
    Sale Purchase Of Stock———-1,397,631USD-4,611,348USD-4,028,177USD-892,928USD-611,610USD
    Cash And Cash Equivalents Changes———-24,788,863USD-179,554,206USD228,504,816USD-1,497,536USD-92,946USD
    Unclassified Operating Cash Flow———4,029,961USD—37,928,455USD—3,417,662USD
    Change To Inventory————15,548,017USD-55,153,615USD935,793USD-963,921USD
    Dividends Paid—————-3,856,557USD-93,235,972USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q3 2022Quarterly · 2022-09-30ProductCELLECTRA2000Device9,000,000USD0001055726-23-000055
    Q3 2022Quarterly · 2022-09-30ProductLicense0USD0001055726-23-000055
    Q3 2022Quarterly · 2022-09-30ProductLicense With Affiliated Entities7,000USD0001055726-23-000055
    Q3 2022Quarterly · 2022-09-30ProductOther147,133USD0001055726-23-000055
    Q2 2022Quarterly · 2022-06-30ProductCELLECTRA2000Device625,000USD0001055726-23-000051
    Q2 2022Quarterly · 2022-06-30ProductLicense0USD0001055726-23-000051
    Q2 2022Quarterly · 2022-06-30ProductLicense With Affiliated Entities6,000USD0001055726-23-000051
    Q2 2022Quarterly · 2022-06-30ProductOther153,395USD0001055726-23-000051
    Q1 2022Quarterly · 2022-03-31ProductLicense65,895USD0001055726-22-000034
    Q1 2022Quarterly · 2022-03-31ProductLicensewith Affiliated Entities9,000USD0001055726-22-000034
    Q1 2022Quarterly · 2022-03-31ProductProduct And Service Other124,337USD0001055726-22-000034
    FY 2021Yearly · 2021-12-31ProductLicense902,260USD0001055726-22-000008
    FY 2021Yearly · 2021-12-31ProductLicensewith Affiliated Entities245,310USD0001055726-22-000008
    FY 2021Yearly · 2021-12-31ProductOther Revenue627,188USD0001055726-22-000008
    FY 2021Yearly · 2021-12-31ProductOther Revenue Affiliated Entity0USD0001055726-22-000008
    Q3 2021Quarterly · 2021-09-30ProductLicense81,447USD0001055726-21-000062
    Q3 2021Quarterly · 2021-09-30ProductLicensewith Affiliated Entities95,136USD0001055726-21-000062
    Q3 2021Quarterly · 2021-09-30ProductProduct And Service Other115,115USD0001055726-21-000062
    Q2 2021Quarterly · 2021-06-30ProductLicense82,923USD0001055726-22-000049
    Q2 2021Quarterly · 2021-06-30ProductLicense With Affiliated Entities75,000USD0001055726-22-000049
    Q2 2021Quarterly · 2021-06-30ProductProduct And Service Other115,114USD0001055726-22-000049
    Q1 2021Quarterly · 2021-03-31ProductLicense39,615USD0001055726-22-000034
    Q1 2021Quarterly · 2021-03-31ProductLicensewith Affiliated Entities50,000USD0001055726-22-000034
    Q1 2021Quarterly · 2021-03-31ProductProduct And Service Other281,556USD0001055726-22-000034
    Q4 2020Quarterly · 2020-12-31ProductLicense5,003,494USD0001055726-21-000018
    Q4 2020Quarterly · 2020-12-31ProductLicensewith Affiliated Entities82,774USD0001055726-21-000018
    Q4 2020Quarterly · 2020-12-31ProductOther Revenue Affiliated Entity494,313USD0001055726-21-000018
    FY 2020Yearly · 2020-12-31ProductLicense5,170,586USD0001055726-22-000008
    FY 2020Yearly · 2020-12-31ProductLicensewith Affiliated Entities1,453,730USD0001055726-22-000008
    FY 2020Yearly · 2020-12-31ProductOther Revenue786,904USD0001055726-22-000008
    FY 2020Yearly · 2020-12-31ProductOther Revenue Affiliated Entity0USD0001055726-22-000008
    Q3 2020Quarterly · 2020-09-30ProductLicense21,490USD0001055726-21-000062
    Q3 2020Quarterly · 2020-09-30ProductLicensewith Affiliated Entities103,684USD0001055726-21-000062
    Q3 2020Quarterly · 2020-09-30ProductProduct And Service Other111,004USD0001055726-21-000062
    FY 2019Yearly · 2019-12-31ProductLicense3,636,945USD0001055726-22-000008
    FY 2019Yearly · 2019-12-31ProductLicensewith Affiliated Entities235,649USD0001055726-22-000008
    FY 2019Yearly · 2019-12-31ProductOther Revenue237,536USD0001055726-22-000008
    FY 2019Yearly · 2019-12-31ProductOther Revenue Affiliated Entity1,800USD0001055726-22-000008
    FY 2018Yearly · 2018-12-31ProductLicense29,860,785USD0001055726-21-000018
    FY 2018Yearly · 2018-12-31ProductLicensewith Affiliated Entities449,524USD0001055726-21-000018
    FY 2018Yearly · 2018-12-31ProductOther Revenue171,588USD0001055726-21-000018
    FY 2018Yearly · 2018-12-31ProductOther Revenue Affiliated Entity0USD0001055726-21-000018
    FY 2017Yearly · 2017-12-31ProductGrant10,474,539USD0001055726-20-000012
    FY 2017Yearly · 2017-12-31ProductGrantwith Affiliated Revenue2,572,331USD0001055726-20-000012
    FY 2017Yearly · 2017-12-31ProductLicense28,407,388USD0001055726-20-000012
    FY 2017Yearly · 2017-12-31ProductLicensewith Affiliated Entities765,828USD0001055726-20-000012
    FY 2016Yearly · 2016-12-31ProductGrant27,136,457USD0001055726-19-000012
    FY 2016Yearly · 2016-12-31ProductGrantwith Affiliated Revenue340,563USD0001055726-19-000012
    FY 2016Yearly · 2016-12-31ProductLicense6,490,747USD0001055726-19-000012
    FY 2016Yearly · 2016-12-31ProductLicensewith Affiliated Entities1,400,594USD0001055726-19-000012

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.